Antimicrobial chemotherapy in the control of surgical infectious complications

Journal of Chemotherapy

Volumn 11, Issue 6, 1999, Pages 440-445

  De Lalla, F ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Antibiotic prophylaxis; Infection; Surgical infections

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ABDOMINAL INFECTION; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIMICROBIAL THERAPY; BACTEROIDES FRAGILIS; CONFERENCE PAPER; DRUG MIXTURE; ENTEROCOCCUS; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTIOUS COMPLICATION; NEPHROTOXICITY; OTOTOXICITY; PENICILLIN RESISTANCE; PLASMID; POSTOPERATIVE INFECTION; PROTEUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; WOUND INFECTION;

EID: 0033378519     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.6.440     Document Type: Conference Paper

References (31)

1. 1 Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50: 161-8.
2. 2 Bernard HL, Cole WR. The prophylaxis of surgical infection: the effect of prophylactic antimicrobial drugs on the incidence of infection following potentially contaminated operations. Surgery 1964; 56: 151-7.
3. 3 Platt R, Zucker JR, Zaleznik DF, et al. Perioperative antibiotic prophylaxis and wound infection following breast surgery. J Antimicrob Chemother 1993; 31 (Suppl B): 43-8.
4. 4 Lewis RT, Weigand FM, Mamazza J, Lloyd-Smith W, Tataryn D. Should antibiotic prophylaxis be used routinely in clean surgical procedures? Tentative yes. Surgery 1995; 118: 742-7.
5. 5 Byrne DJ, Lynch W, Napier A, Davey P, Malek M, Cuschieri A. Wound infection rates: the importance of definition and post-discharge wound surveillance. J Hosp Infect 1994; 26: 37-43.
6. 6 Hulton LJ, Olmsted RN, Treston-Aurand J, Craig CP. Effect of postdischarge surveillance on rates of infectious complications after cesarean section. Am J Infect Control 1992; 20: 198-201.
7. 7 Holtz TH, Wenzel RP. Postdischarge surveillance for nosocomial wound infection: a brief review and commentary. Am J Infect Control 1992; 20: 206-13.
8. 8 Sands K, Vineyard G, Platt R. Surgical site infections occurring after hospital discharge. J Infect Dis 1996; 173: 963-70.
9. 9 Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM. Identifying patients at high risk of surgical wound infection: a simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985; 121: 206-15.
10. 10 Moro ML, Stazi MA, Marasca G, Greco D, Zampieri A. National prevalence survey of hospital-acquired infections in Italy, 1983. J Hosp Infect 1986; 8: 72-85.
11. 11 Green JW, Wenzel RP. Postoperative wound infection: a controlled study of the increased duration of hospital stay and direct cost of hospitalisation. Ann Surg 1977; 185: 264-8.
12. 12 Beyt BE Jr, Troxler S, Cavaness J. Prospective payment and infection control. Infect Control 1985; 6: 161-4.
13. 13 Haley RW, White JW, Culver DH, Hughes JM. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system. An empirical determination from a nationally representative sample. JAMA 1987; 257: 1611-4.
14. 14 Haley RW, Schaberg DR, Von Allmen SD, McGowan JE Jr. Estimating the extra charges and prolongation of hospitalisation due to nosocomial infections: a comparison of methods. J Infect Dis 1980; 141: 248-57.
15. 15 Wenzel RP. Preoperative antibiotic prophylaxis. N Engl J Med 1992; 326: 337-9.
16. 16 Nafziger DA, Saravolatz LD. Infection in implantable prosthetic devices. In: Prevention and control of nosocomial infections, third edition; R. Wenzel Editor, Baltimore: Williams & Wilkins, 1997: 889-923.
17. 17 Edmiston CE Jr, Schmitt DD, Seabrook GR. Coagulase-negative staphylococcal infections in vascular surgery: epidemiology and pathogenesis. Infect Control Hosp Epidemiol 1989; 10: 111-7.
18. 18 Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ. Risk factors for the development of prosthetic valve endocarditis. Circulation 1985; 72: 31-7.
19. 19 Karchmer AW, Archer GL, Dismukes WE. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiology and clinical observations as guides to therapy. Arch Intern Med 1983; 98: 447-55.
20. 20 Kaiser AB, Petracek MR, Lea JW, et al. Efficacy of cefazolin, cefamandole and gentamicin as prophylactic agents in cardiac surgery: Results of a prospective, randomized, double-blind trial in 1030 patients. Ann Surg 1987; 206: 791-7.
21. 21 Slama TG, Sklar SJ, Misinski J, Fess SW. Randomized comparison of cefamandole, cefazolin, and cefuroxime prophylaxis in open-heart surgery. Antimicrob Agents Chemother 1986; 29: 744-7.
22. 22 Maki DG,Bohn MJ, Stolz SM, Kroncke GM, Archer CW, Meyerowitz PD. Comparative study of cefazolin, cefamandole and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. J Thorac Cardiovasc Surg 1992; 104: 1423-34.
23. 23 Nichols RL. Prevention of infection in high risk gastrointestinal surgery. Am J Med 1984; 76: 111-9.
24. 24 Davey P, Vacani P, Parker SE, Malek MM. Assessing cost effectiveness of antimicrobial treatment: monotherapy compared with combination therapy. Eur J Surg 1994; Suppl 573: 67-72.
25. 25 Chang DC, Wilson SE. Meta-analysis of the clinical outcome of carbapenem monotherapy in the adjunctive treatment of intra-abdominal infections. Am J Surg 1997; 174: 284-90.
26. 26 Sanders WE, Sanders CC. Piperacillin/tazobactam: a critical review of the evolving clinical literature. Clin Infect Dis 1996; 22: 197-23.
27. 27 Legrand JC, Bastin F, Belva P, Chastel C, Renaux J, Van Eukem P. Piperacillin-tazobactam treatment for severe intra-abdominal infections. Acta Chir Belg 1995; 95: 162-5.
28. 28 Jaccard C, Troillet S, Harbarth S, et al. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis. Antimicrob Agent Chemother 1998; 42: 2966-72.
29. 29 Wilson SE, Nord CE. Clinical trials of extended spectrum penicillin/beta-lactamase inhibitors in the treatment of intra-abdominal infections. Am J Surg 1995; 169 (Suppl 5A): 21S-26S.
30. 30 Polk HC Jr, Kink MP, Leverdiere M, et al. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. Am Surg 1993; 59: 598-605.
31. 31 Salomone JP, Nichols R L. Intra-abdominal surgical infections. In: Infectious diseases in critical care medicine, B.A. Cunha ed, New York: Marcel Dekker Inc, 1998: 461-88.